Dacogen (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Dacogen drug offered from Otsuka America Pharmaceutical, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | decitabine |
| SUBSTANCE NAME: | DECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-05-03 |
| END MARKETING DATE: | 0000-00-00 |
Dacogen HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dacogen from Otsuka America Pharmaceutical, Inc. |
| LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/20mL) |
| START MARKETING DATE: | 1996-05-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59148-046_e1591080-2107-4acd-8f52-465a209cc1a9 |
| PRODUCT NDC: | 59148-046 |
| APPLICATION NUMBER: | NDA021790 |
Other DECITABINE Pharmaceutical Manufacturers / Labelers:
